Advantage of Prevention and Treatment in Neonatal Respiratory Distress Syndrome
- 1 January 2013
- journal article
- Published by Hans Publishers in Asian Case Reports in Pediatrics
- Vol. 01 (01), 10-15
- https://doi.org/10.12677/acrp.2013.11003
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Synthetic Surfactant Based on Analogues of SP-B and SP-C Is Superior to Single-Peptide Surfactants in Ventilated Premature RabbitsNeonatology, 2010
- Coventina's ColumnScottish Medical Journal, 2008
- Surfactant Replacement TherapySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- Physiology of Fetal Lung Fluid Clearance and the Effect of LaborSeminars in Perinatology, 2006
- Effects of prenatal betamethasone exposure on regulation of stress physiology in healthy premature infantsPsychoneuroendocrinology, 2004
- Genetic Disorders of Neonatal Respiratory FunctionPediatric Research, 2001
- Antenatal Use of Ambroxol for the Prevention of Infant Respiratory Distress SyndromeJournal of Obstetrics and Gynaecology Research, 2000
- Antenatal ambroxol treatment does not prevent the respiratory distress syndrome in premature infants.European Journal of Pediatrics, 1997
- Regulation of phosphatidylcholine synthesis in maturing type II cells: increased mRNA stability of CTP:phosphocholine cytidylyltransferaseBiochemical Journal, 1996
- Expression and Localization of Epidermal Growth Factor, Transforming Growth Factor-α, and Localization of Their Common Receptor in Fetal Human Lung DevelopmentPediatric Research, 1996